fascin inhibitors (Novita Pharmaceuticals)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namefascin inhibitors (Novita Pharmaceuticals)
Drug Alias Namecore macroketonecore macrolactamfascin inhibitors (Weill Medical College of Cornell University/Memorial Sloan-Kettering Cancer Center)migrastatin analogs (MSKCC)migrastatin analogs (MSKCC/Weill Medical College of Cornell University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFascin inhibitors
TargetsFascin
Therapy Area/IndicationsNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMemorial Sloan Kettering Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWeill Medical College of Cornell UniversityNovita Pharmaceuticals IncMemorial Sloan Kettering Cancer Center
Active IndicationsN/A
Inactive IndicationsNeoplasm Metastasis

Other Information

ATC CodeN/A
Related LinksN/A